Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
46.67
-0.75 (-1.58%)
At close: Dec 5, 2025, 4:00 PM EST
46.60
-0.07 (-0.15%)
After-hours: Dec 5, 2025, 5:48 PM EST
Crinetics Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -423.1 | -298.41 | -214.53 | -163.92 | -107.64 | -73.81 | |
| Depreciation & Amortization | 3.68 | 2.79 | 1.1 | 0.98 | 0.92 | 0.95 | |
| Loss (Gain) From Sale of Assets | 0.04 | 0.05 | 0.01 | - | - | - | |
| Loss (Gain) From Sale of Investments | -16.85 | -14.93 | -6.27 | 0.03 | 0.42 | -0.23 | |
| Loss (Gain) on Equity Investments | - | 0.47 | 5.2 | 1.01 | - | - | |
| Stock-Based Compensation | 88.15 | 69.39 | 40.94 | 28.27 | 17.35 | 10.43 | |
| Other Operating Activities | 3.12 | 3.04 | -0.79 | -0.19 | -0.74 | 0.26 | |
| Change in Accounts Payable | 28.15 | 17.54 | 14.65 | 10.99 | 6.29 | 2.72 | |
| Change in Unearned Revenue | -1.13 | 0.07 | -1.54 | 8.34 | - | - | |
| Change in Other Net Operating Assets | -29.73 | -5.98 | -5.07 | -0.72 | -5.2 | -2.35 | |
| Operating Cash Flow | -347.67 | -225.97 | -166.31 | -115.21 | -88.59 | -62.03 | |
| Capital Expenditures | -6.33 | -3.84 | -4.69 | -1.66 | -0.44 | -0.19 | |
| Investment in Securities | -418.95 | -570.97 | -195.73 | -172.32 | -56.05 | 0.4 | |
| Investing Cash Flow | -425.29 | -574.82 | -200.41 | -173.98 | -56.48 | 0.22 | |
| Issuance of Common Stock | 600.08 | 1,060 | 411.68 | 129.72 | 265.64 | 122.07 | |
| Other Financing Activities | -33.49 | -49.44 | -22.74 | -7.76 | -12.96 | -7.5 | |
| Financing Cash Flow | 566.59 | 1,010 | 388.94 | 121.96 | 252.68 | 114.57 | |
| Net Cash Flow | -206.37 | 209.65 | 22.22 | -167.22 | 107.61 | 52.76 | |
| Free Cash Flow | -354 | -229.81 | -171 | -116.86 | -89.02 | -62.21 | |
| Free Cash Flow Margin | -23061.95% | -22118.77% | -4261.03% | -2466.98% | -8258.26% | -87623.94% | |
| Free Cash Flow Per Share | -3.80 | -2.85 | -2.94 | -2.25 | -2.32 | -2.04 | |
| Levered Free Cash Flow | -205.66 | -136.41 | -93.53 | -62.51 | -48.47 | -35.28 | |
| Unlevered Free Cash Flow | -205.66 | -136.41 | -93.53 | -62.51 | -48.47 | -35.28 | |
| Change in Working Capital | -2.71 | 11.64 | 8.04 | 18.61 | 1.1 | 0.38 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.